Username Password
S&P 500: 2,117.69
Change: +0.23%

GLAXOSMITHKLINE PLC (GSK)

Overview
Price 46.59
Price Change Today +$0.28 (+0.60%)
P&P rating Rating: 4
Open Price $46.23
Previous Close $46.31
Daily Range $46.12 - $46.80
52-Week Range $41.25 - $56.48
Volume 3
chart
Top Buy Analysis
BUY: GSK Rating: 4
Company: GLAXOSMITHKLINE PLC
Points: -0.84
Start Price: $46.04
Start Date: 12/05/2014 11:50 AM
olautern
olautern
P&P Score: 93.88
Recs:
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Top Sell Analysis
No Sell Analysis. Be the First.
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

52 Buy
0 Sell
 
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.99 11/06/10 Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) latest holdings as of the close on June 30, 2010 4 11/15/10
AndrewGreenBull
96.13 02/03/10 XNPT—Volatility or Opportunity? 0
AndrewGreenBull
96.13 01/20/10 FDA Calendar Focus: XNPT 0
Zacks_Analysts
0.00 06/04/13 Glaxo/Renaissance Ink Deal - Analyst Blog 0
Zacks_Analysts
0.00 02/13/13 Theravance Narrows Y/Y Loss - Analyst Blog 0
Zacks_Analysts
0.00 02/13/13 Theravance Narrows Y/Y Loss - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Bayer Seeks Riociguat Approval - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Bayer Seeks Riociguat Approval - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Life's Products Gain FDA Approval - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Life's Products Gain FDA Approval - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   ...  66  >>
Commentary
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -0.84
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -0.23
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -0.38
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -0.84
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -0.23
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $46.04
Points: -0.38
Created: 12/05/2014
Postive devalopement with Ebola Vaccine; Colaboration with Novartis; stock bottoming out; seems to be a good base for getting in.

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $33.46
Points: -55.15
Created: 05/28/2010
#1 Quality
#2 Price

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $33.46
Points: -53.98
Created: 05/28/2010
#1 Quality
#2 Price

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $33.46
Points: -54.25
Created: 05/28/2010
#1 Quality
#2 Price

Comments: 0 | Comment

Recs:
 
BUY: GLAXOSMITHKLINE PLC (GSK) Rating: 4
Start Price: $33.46
Points: -55.15
Created: 05/28/2010
#1 Quality
#2 Price

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3   4   5   6  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
olautern 93.88 BUY Week to a Month 12/05/2014 $46.04 $46.59
(+0.60%)
+1.19% +2.04% -0.84 view
olautern 93.88 BUY Week to a Month 12/05/2014 $46.04 $46.59
(+0.60%)
+1.19% +1.43% -0.23 view
olautern 93.88 BUY Week to a Month 12/05/2014 $46.04 $46.59
(+0.60%)
+1.19% +1.57% -0.38 view
olautern 93.88 BUY Week to a Month 12/05/2014 $46.04 $46.59
(+0.60%)
+1.19% +2.04% -0.84 view
olautern 93.88 BUY Week to a Month 12/05/2014 $46.04 $46.59
(+0.60%)
+1.19% +1.43% -0.23 view
olautern 93.88 BUY Week to a Month 12/05/2014 $46.04 $46.59
(+0.60%)
+1.19% +1.57% -0.38 view
vip 70.64 BUY One to Three Months 02/16/2012 $44.98 $46.59
(+0.60%)
+3.58% +55.94% -52.36
vip 70.64 BUY One to Three Months 02/16/2012 $44.98 $46.59
(+0.60%)
+3.58% +55.00% -51.42
vip 70.64 BUY One to Three Months 02/16/2012 $44.98 $46.59
(+0.60%)
+3.58% +55.22% -51.64
vip 70.64 BUY One to Three Months 02/16/2012 $44.98 $46.59
(+0.60%)
+3.58% +55.94% -52.36
Pages: [ 1 ]  2   3   4   5   6  >>
Sponsored Links